Healthcare shares surged as investors sought out sectors less reactive to inflation.
Moderna said it has asked U.S. health regulators to authorize the use of its Covid-19 shot in adolescents ages 12 to 17, setting up the potential availability of a second vaccine option for adolescents that could be cleared for use this summer. Meanwhile, the U.S. government has halted new shipments of the Johnson & Johnson Covid-19 vaccine, according to state and federal health officials, one of several steps federal agencies are taking that could help clear a backlog of unused doses before they expire.
Eli Lilly plans to ask the Food and Drug Administration whether its thinking has changed on the timeline for Lilly to seek FDA approval of its experimental Alzheimer's disease drug donanemab. This comes in the wake of the FDA's approval Monday of an Alzheimer's drug from Biogen, with the agency basing its approval on that drug's ability to reduce a substance called amyloid plaque in the brain. Lilly's drug also reduced plaque levels in patients in a small, midstage study released earlier this year.
Mental-health care startup Cerebral has secured $127 million in new financing as demand soars for tools to combat conditions such as depression and anxiety.
Write to Amy Pessetto at amy.pessetto@dowjones.com
(END) Dow Jones Newswires
06-10-21 1716ET
